Skip to main navigation

Contact Us
Careers
Press Releases
LinkedIn

About Us
About Us
Medicines
Pipeline
Pipeline
- Anaphylm™
- Libervant®
Technologies
Services
Our Responsibilities
Investors
Investors

About Us
Medicines
Pipeline
- Anaphylm™
- Libervant®
Technologies
Services
Our Responsibilities
Investors

Contact Us
Careers
Press Releases
LinkedIn

Breadcrumb

Home Investors Events and Presentations

Events and Presentations

Presentations

Corporate Presentation – February 2026 1.8 MB

Anaphylm™ (dibutepinephrine) Sublingual Film Complete Response Letter Supplemental Material 1.1 MB

Anaphylm Pre-NDA Meeting Supplemental Material 525.4 KB

Anaphylm™ (epinephrine) Sublingual Film Oral Allergy Syndrome Challenge Study Supplemental Materials 1.5 MB

Anaphylm™ (epinephrine) Sublingual Film Pivotal Study and Type C Meeting Supplemental Materials 1.5 MB

Anaphylm™(epinephrine) Sublingual Film Pilot Clinical Studies Supplemental Materials 778.4 KB

AQST-109: EPIPHAST II Results 2 MB

AQST-109: Topline Results from Phase 1 PK Study 594.4 KB

Upcoming Events

There are no upcoming events available at this time.

Past Events

08.12.25 8:00 AM EDT

Q2 2025 Aquestive Therapeutics, Inc. Earnings Conference Call

Click here for webcast

View Presentation 1.5 MB

05.13.25 8:00 AM EDT

Q1 2025 Aquestive Therapeutics, Inc. Earnings Conference Call

Click here for webcast

View Presentation 708.5 KB

05.08.25 10:00 AM EDT

Citizens Life Sciences Conference

Click here for webcast

03.10.25 4:10 PM EDT

Leerink's Global Healthcare Conference 2025

Click here for webcast

03.06.25 8:00 AM EST

Q4 2024 Aquestive Therapeutics, Inc. Earnings Conference Call

Click here for webcast

View Presentation 754.8 KB

02.11.25 3:20 PM EST

Oppenheimer 35th Annual Healthcare Conference

Click here for webcast

11.05.24 8:00 AM EST

Q3 2024 Aquestive Therapeutics, Inc. Earnings Conference Call

Click here for webcast

View Presentation 829.6 KB

09.27.24 8:00 AM EDT

Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th

Click here for webcast

View Presentation 4.1 MB

09.09.24 8:30 AM EDT

H.C. Wainwright 26th Annual Global Investor Conference

Click here for webcast

View Presentation 1.8 MB

08.07.24 8:00 AM EDT

Q2 2024 Aquestive Therapeutics, Inc. Earnings Conference Call

Click here for webcast

View Presentation 740.6 KB

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
…
Next page
Last page

Subscribe to our Email Alerts

Receive the latest posters, presentations, and data with our clinical trial portal.

Email Address Required

Email Alerts
Investor Contact
Investor FAQs
RSS Feeds

Advancing medicines to bring meaningful

improvement to patients' lives through

innovative science and delivery technologies

Cookie Settings
Privacy Policy
Contact Us
Privacy Notice for California Residents
Terms of Use

Do Not Sell or Share My Information

© Aquestive Therapeutics, Inc. PharmFilm®, Libervant®, and the Aquestive logo are registered trademarks of Aquestive Therapeutics, Inc. All rights reserved. All other registered trademarks referenced herein are the property of their respective owners.